Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
|
San Antonio, TX
-
View from the Trenches: Key clinical practice takeaways from SABCS 20
The final day of SABCS 20 included the session “View from the Trenches: What Will You Do on Monday Morning,” featuring a multidisciplinary panel of experts who discussed some of the most important data and study findings presented during the meeting.
-
McGuire Lecturer echoes call for universal genetic testing for BRCA1/2 mutations
In this year’s William L. McGuire Memorial Lecture, Mary-Claire King, PhD, called for universal testing of women for BRCA1 and BRCA 2 mutations to prevent breast and ovarian cancer.
-
AACR Distinguished Lectureship in Breast Cancer Research: Biomarkers offer insight into breast cancer risk prediction
Large prospective cohort studies have provided valuable insights into breast cancer risk at the population level. But broad characteristics such as age, body mass index, type of cancer, age at diagnosis, and progression are just the beginning.
-
AACR Outstanding Investigator Award for Breast Cancer Research: Using genomics to better understand the breast cancer microenvironment
Tumor infiltrating lymphocytes are an immunologic novelty that is moving toward clinical utility in breast cancer prognosis and treatment selection. In her AACR Award Lecture, Sherene Loi, PhD, FRACP, described ongoing research into the role of TILs in breast cancer prognosis and progression.
-
Don’t forget to complete your SABCS session surveys
Use the SABCS mobile app to complete session surveys and evaluations for the sessions you attended. Please be sure to go through the entire survey to ensure you receive the proper credit.
-
Thanks for attending SABCS 20!
With the SABCS 20 Virtual Symposium in the books, the SABCS Executive and Program Planning committees would like to thank everyone who participated in planning and presenting this year’s meeting, and a special thanks to everyone across the globe who attended.
-
Year in Review session summarizes progress in a challenging year
It is certainly no understatement to say that 2020 has been a very tough year in many ways, but it has not stopped scientific progress and the great strides and studies that have been reported over the course of the year.
-
Debate examines pros and cons of genetic testing for all BCa patients
Should all breast cancer patients have germline genetic testing? That is a topic getting a lot of attention and was the question tackled by a pair of expert clinician-scientists during a special SABCS 20 debate.
-
Brinker Clinical Research Award Lecture: Delivering personalized care for breast cancer patients
The I-SPY trials have become models to accelerate the development of personalized treatment for breast cancer patients. In this year’s Brinker Clinical Research Award Lecture, I-SPY Principal Investigator Laura Esserman, MD, MBA, discussed the vision and goals for I-SPY 2 and beyond.
-
Brinker Basic Science Award Lecture: Which is best — SERMs or SERDs — for treating BCa?
As one of the world’s leading experts in the science of estrogen receptor signaling and a pioneer in the development of SERMs and SERDs, Donald McDonnell, PhD, says one of the questions he is asked most frequently is which of these is most suitable and most likely to work best in metastatic breast cancer.